Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-26 @ 12:38 AM
Study NCT ID:
NCT03458260
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-09
First Post:
2018-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-26
First Submit QC Date:
None
Study First Post Date:
2018-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL